Associated tags: Patient, Medical Devices, Health, NYSE, Electromation Inc, Medical Supplies, General Health, Domestic, International, Health Technology, Other Health
Locations: UNITED STATES, NORTH AMERICA, MINNESOTA, VA, US
Medical Supplies,
Health,
Medical Devices,
Manufacturing,
Health Technology,
General Health,
Other Manufacturing,
International,
Investment,
Domestic,
Wind,
Patient,
Marketing Net revenues increased 15% to a record $13.9 million in Q3 FY 2024, from $12.1 million in the third quarter of the prior fiscal year.
Key Points:
- Net revenues increased 15% to a record $13.9 million in Q3 FY 2024, from $12.1 million in the third quarter of the prior fiscal year.
- Operating income increased by 54% to $1,841,000 or 13% of revenue, compared with $1,196,000 or 10% of revenue in the third quarter of the prior fiscal year.
- Net income was $1,493,000 for the quarter, or $0.17 per diluted share, compared to $1,075,000, or $0.12 per diluted share in the third quarter of the prior fiscal year.
- “I am excited to announce another record revenue quarter in the third quarter of fiscal year 2024,” said Jim Cunniff, President, and Chief Executive officer.
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 third quarter ended March 31, 2024, on May 7, 2024 after the close of the stock market.
Key Points:
- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 third quarter ended March 31, 2024, on May 7, 2024 after the close of the stock market.
- Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
- The live conference call webcast will be accessible in the Investor Relations section of Electromed’s website and directly via the following link: https://viavid.webcasts.com/starthere.jsp?ei=1665471&tp_key=f09d972070
For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Domestic) or (412) 317-6671 (International) and referencing the replay pin number 10187972.
- Additionally, an online replay will be available in the Investor Relations section of Electromed’s web site at: https://investors.smartvest.com/events-and-presentations/default.aspx
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024.
Key Points:
- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024.
- Electromed’s management team will present at 10:30 a.m. Eastern Time on Thursday, April 18, 2024.
- To view the live webcast, you can register for the conference for free, here .
- An archived webcast of the event will be available shortly after the event on the Electromed website under Events & Presentations .
Retrieved on:
Wednesday, February 28, 2024
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024.
Key Points:
- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024.
- Electromed’s management team will present at 10:45 a.m. Eastern Time on Wednesday, March 13, 2024.
- A live and archived webcast of the event will be available on the Electromed website under Events & Presentations .
- You can also access the live webcast directly, here .
Retrieved on:
Tuesday, February 13, 2024
Other Manufacturing,
Medical Supplies,
General Health,
Health,
Medical Devices,
Health Technology,
Manufacturing,
Other Health,
Marketing,
Domestic,
International,
Growth,
Investment Net revenue increased 17% to a record $13.7 million in Q2 FY 2024, from $11.7 million in the second quarter of the prior fiscal year.
Key Points:
- Net revenue increased 17% to a record $13.7 million in Q2 FY 2024, from $11.7 million in the second quarter of the prior fiscal year.
- Gross margins were 77% of revenue, compared to 74% in the second quarter of the prior fiscal year.
- Operating income was a record $2,263,000 or 16.5% of revenue, compared with $1,274,000 or 10.1% of revenue in the second quarter of the prior fiscal year.
- Net income was a record $1,674,000 for the quarter, or $0.19 per diluted share, compared to $977,000, or $0.11 per diluted share in the second quarter of the prior fiscal year.
Retrieved on:
Tuesday, January 30, 2024
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February 13, 2024 after the close of the stock market.
Key Points:
- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February 13, 2024 after the close of the stock market.
- Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
- The live conference call webcast will be accessible in the Investor Relations section of Electromed’s website and directly via the following link: https://viavid.webcasts.com/starthere.jsp?ei=1650986&tp_key=12e0064318
For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Domestic) or (412) 317-6671 (International) and referencing the replay pin number 13743606.
- Additionally, an online replay will be available in the Investor Relations section of Electromed’s web site at: https://investors.smartvest.com/events-and-presentations/default.aspx
White House,
Federal Government,
Other Health,
Healthcare Reform,
Small Business,
General Health,
Professional Services,
Medical Devices,
Defense,
Public Policy,
Government,
Transport,
Native American,
Veterans,
Logistics,
Supply Chain Management,
Consumer,
Health,
Medical Supplies,
Patient,
SDVOSB,
Health care,
Indian Health Service,
Partnership,
Federal,
Risk,
Quality of life,
Veteran,
Urinary tract infection,
Atmosphere,
Native Americans,
Mucus Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB).
Key Points:
- Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB).
- SmartVest® Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy, a clinically proven therapy that helps clear the lungs of excess secretions, thereby reducing the risk of respiratory infections and hospitalizations for those suffering from a chronic lung condition.1 As a distribution partner, Marathon Medical focuses on providing medical products to Federal agencies including VA hospitals and clinics, Indian Health Service hospitals and clinics, and other Federal agencies.
- “This partnership will improve the ordering process for all government facilities allowing easier access to our products, so veterans can breathe easier and live better,” said Jim Cunniff, President and Chief Executive Officer of Electromed.
- The SmartVest Clearway system is indicated for use in patients managing non-cystic fibrosis bronchiectasis (NCFB) and other chronic pulmonary conditions.
Retrieved on:
Wednesday, January 24, 2024
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual 2024 Lytham Partners Investor Select Conference on February 1, 2024.
Key Points:
- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual 2024 Lytham Partners Investor Select Conference on February 1, 2024.
- Electromed’s management team will engage in a fireside chat and investor 1x1s.
- The fireside chat is scheduled to take place at 11 am Eastern Time on February 1, 2024.
- To register for the fireside chat, please use the following link: https://wsw.com/webcast/lytham10/elmd/2071712
Retrieved on:
Tuesday, November 7, 2023
Health Technology,
Health,
Medical Supplies,
Medical Devices,
Physician,
Documentation,
Texas Homecare,
Domestic,
Marketing,
NYSE,
International,
Clearway,
Security (finance),
Health insurance,
Video game,
Electromation Inc Net revenue increased 16% to $12.3 million in Q1 FY 2024, from $10.7 million in the first quarter of the prior fiscal year.
Key Points:
- Net revenue increased 16% to $12.3 million in Q1 FY 2024, from $10.7 million in the first quarter of the prior fiscal year.
- Operating income was $142,000, compared with $44,000 in the first quarter of the prior fiscal year.
- Net income was $155,000 for the quarter, or $0.02 per diluted share, compared to $81,000, or $0.01 per diluted share in the first quarter of the prior fiscal year.
- I am proud of the team for an impressive start to fiscal year 2024 and look forward to building on this momentum in the remainder of the fiscal year.”
Net revenue for Q1 FY 2024 grew 16% over the first quarter of our fiscal year ended June 30, 2023 (“fiscal 2023”) to $12.3 million, from $10.7 million in the same period in fiscal 2023.
Retrieved on:
Wednesday, November 1, 2023
Medical Supplies,
Medical Devices,
Health,
Hospitals,
Health Technology,
Managed Care,
Quality of life,
Muscle weakness,
NYSE,
Risk,
Atmosphere,
Patient,
Ventilation,
Mucus,
Hospital,
Electromation Inc Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced its launch of the SmartVest® Clearway® Airway Clearance System to the hospital market for inpatient use.
Key Points:
- Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced its launch of the SmartVest® Clearway® Airway Clearance System to the hospital market for inpatient use.
- “SmartVest Clearway provides therapeutic relief for patients suffering from ineffective secretion clearance due to muscle weakness, ineffective cough, or impaired ventilation.
- The intuitive system is designed to help hospital staff speed patient recovery for patients with dysfunctional airway clearance,” commented Jim Cunniff, President and Chief Executive Officer of Electromed.
- “We are proud to further our mission in assisting more patients to breathe easier, improve their quality of life, and prevent hospital readmissions.”
